Mission: Possible symposium discusses patient involvement in research
iCAN, the flagship of digital personalised cancer medicine, and the Finnish Cancer Institute Foundation are organising the symposium Mission: Possible…
Satu Mustjoki new iCAN Scientific Director
iCAN Steering Board supported today the nomination of Satu Mustjoki as iCAN’s new Scientific Director. The Steering Board also expressed its…
iCAN Webinar Recordings: Implementing transparent and high-quality real-world data networks for evidence generation at scale
The webinar held on May 11, 2022 focused on how to implement high-quality, harmonized RWD/RWE networks for cancer research, decision…
FCAI x iCAN workshop
The iCAN-FCAI workshop will bring together top researchers from both flagships, with the goal to present and discuss issues from ongoing…
iCAN flagship partnership in precision cancer medicine launched
iCAN aims for discoveries and improved treatments through research at the interface of precision cancer medicine and digital health. The…
New research highlights clinical importance of interaction between immune cells in the lymphoma microenvironment
The efficacy of immunotherapies in the most common lymphoid malignancy, diffuse large B-cell lymphoma, has been modest. New findings on…
What exactly is cancer? Can we beat it?
What do we know about cancer, and what are some of the current cancer research trends? This article highlights key…
The secret hideouts of ovarian cancer revealed – Findings boost the development of precision therapies
Researchers at the University of Helsinki discovered how ovarian cancer hides from the body’s immune system. The findings will help…
Introducing new podcast miniseries about cancer research
What are the latest advances in cancer research and treatment? Listen to our new podcast miniseries to find out! The…
iCAN receives 14 million euro grant to promote development of personalized treatments for cancer
iCAN has received a grant of 14 million euros from the Academy of Finland for its second term. Coordinated by…
End of content
End of content